ACVRL1 Rabbit anti-Human, Polyclonal, Invitrogen
Rabbit Polyclonal Antibody
Manufacturer: Invitrogen PA527477
PA5-27477 targets Activin A Receptor Type II-like 1 in WB applications and shows reactivity with Human samples. The PA5-27477 immunogen is recombit fragment corresponding to a region within amino acids 311 and 503 of Human Activin A Receptor Type II-like 1. Store product as a concentrated solution. Centrifuge briefly prior to opening the vial. For short-term storage (1-2 weeks), product can be stored at 4°C. For long-term storage, aliquot and store product at -20° C or below, avioiding multiple freeze-thaw cycles.This gene encodes a type I cell-surface receptor for the TGF-beta superfamily of ligands. It shares with other type I receptors a high degree of similarity in serine-threonine kinase subdomains, a glycine- and serine-rich region (called the GS domain) preceding the kinase domain, and a short C-terminal tail. The encoded protein, sometimes termed ALK1, shares similar domain structures with other closely related ALK or activin receptor-like kinase proteins that form a subfamily of receptor serine/threonine kinases. Mutations in this gene are associated with hemorrhagic telangiectasia type 2, also known as Rendu-Osler-Weber syndrome 2.
|Recombit fragment corresponding to a region within amino acids 311 and 503 of Human Activin A Receptor Type II-like 1|
|Antigen affinity chromatography|
|PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7|
|ACVRLK1, ALK-1, ALK1, HHT, HHT2, ORW2, SKR3, TSR-I, TGF-B superfamily receptor type I, activin A receptor, type II-like kinase 1, activin receptor-like kinase 1, serine/threonine-protein kinase receptor R3|
|Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok